Topline:
A landmark 20-year study has provided unprecedented insights into the early biomarker changes associated with sporadic Alzheimer's disease (AD), charting a course for potentially earlier diagnosis and intervention strategies. This breakthrough offers patients and healthcare providers critical information on the timing of amyloid-beta, tau, and n…
